Updates, advisories and surprises
By MarketWatch
Last Update: 4:31 PM ET Apr 10, 2008
(4:18 PM ET) BOSTON (MarketWatch) — Genentech Inc.(DNA)reported a 12% boost in
its bottom-line late Thursday, due largely to increased sales for its cancer
medications. For the quarter ended March 31, Genentech posted net income of $790
million, compared with $706 million for the previous year’s quarter. [...]